2017 Symposium to Feature New Insights for Patient Care After Cancer Treatment

For immediate release
January 26, 2017

Contact

Alise Fisher
571-483-1354

SAN DIEGO – Five studies highlighting notable research on survivorship care will be presented at the 2017 Cancer Survivorship Symposium, taking place January 27-28 at the Manchester Grand Hyatt in San Diego. These select abstracts provide a better understanding of the risks associated with treatment and the late effects of cancer.

Experts in survivorship care are available on-site to comment on the studies below.

Abstract 102:
Metabolic syndrome (MetS) after platinum-based chemotherapy (CHEM): A multicenter study of North American testicular cancer survivors (TCS).

Poster Session A
Friday, January 27, 2017: 12:15 PM – 1:45 PM PST
Friday, January 27, 2017: 5:15 PM – 6:15 PM PST
Manchester Grand Hyatt, Grand Ballroom, Salon C, Lobby Level

Mohammad Issam Abu Zaid, MBBS
Indiana University School of Medicine
Indianapolis, Indiana

Abstract 105:
Risk of coronary heart disease and ischemic stroke in thyroid cancer patients taking levothyroxine.

Oral Abstract Session B
Saturday, January 28, 2017: 11:25 AM – 11:35 AM PST
Grand Hyatt, Seaport Ballroom, Salon E, Seaport Tower, 2nd Floor

Dong Wook Shin
Seoul National University Hospital
Seoul, South Korea

Abstract 120:
Brentuximab-induced peripheral neuropathy: Risk factors and patient experiences.

Poster Session B
Saturday, January 28, 2017: 7:00 AM – 7:55 AM PST
Saturday, January 28, 2017: 12:15 PM – 1:45 PM PST
Manchester Grand Hyatt, Grand Hall Salon C, Lobby Level

Sarah Nagle, MD
Abramson Cancer Center of the
University of Pennsylvania
Philadelphia, PA

Abstract 137:
Late effects among head and neck cancer survivors in Utah cancer survivorship study.

Poster Session B
Saturday, January 28, 2017: 7:00 AM – 7:55 AM PST
Saturday, January 28, 2017: 12:15 PM – 1:45 PM PST
Manchester Grand Hyatt, Grand Hall Salon C, Lobby Level

Daisuke Kawakita, MD, PhD
University of Utah, School of Medicine
Salt Lake City, Utah

Abstract 146:
Immediate-term Chemotherapy-Related Cognitive Impairment (CRCI) Following Administration of Intravenous (IV) Chemotherapy.

Poster Session B
Saturday, January 28, 2017: 7:00 AM – 7:55 AM PST
Saturday, January 28, 2017: 12:15 PM – 1:45 PM PST
Manchester Grand Hyatt, Grand Hall Salon C, Lobby Level

Omar Farooq Khan, MD
University of Calgary Faculty of Medicine
Calgary, Alberta

2017 Cancer Survivorship Symposium News Planning Team:
Merry Jennifer Markham, MD, FACP, American Society of Clinical Oncology (ASCO); Lewis Foxhall, MD, FAAFP, American Academy of Family Physicians (AAFP); Carol Rosenberg, MD, FACP, American College of Physicians (ACP).

View the disclosures for the News Planning Team.

ATTRIBUTION TO THE 2017 CANCER SURVIVORSHIP SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.

###

About the American Academy of Family Physicians:
The American Academy of Family Physicians (AAFP) and its chapters represent more than 124,900 family physician, resident, and medical student members. The organization assists family practices in improving the health of patients, families, and communities by advancing the specialty of family medicine. Visit aafp.org to learn more.

About the American College of Physicians:
The American College of Physicians (ACP) has 148,000 members, including internists, internal medicine subspecialists, and medical students, residents, and fellows. The organization is the largest medical-specialty organization and second-largest physician group in the United States and is dedicated to helping apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults. To learn more, visit acponline.org.

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.